Literature DB >> 3832055

In vitro characteristics of tobramycin-PMMA beads: compressive strength and leaching.

D K Kirkpatrick, L S Trachtenberg, P D Mangino, J A Von Fraunhofer, D Seligson.   

Abstract

Antibiotic-impregnated polymethylmethacrylate (PMMA) bone cement beads have been used as a local drug delivery system for the treatment of bone and soft tissue infections. The beads deliver a high local level of antibiotic with a decreased risk of toxic systemic levels. This study was undertaken to determine the antibiotic release characteristics of tobramycin-impregnated beads over time and to determine the compressive strength of these beads. Acrylic resin (PMMA) bone cement beads were prepared with three different concentrations of tobramycin. The beads were tested for compressive strength, and their antibiotic release characteristics were determined over a 21 day period by radioimmunoassay and by biological testing against a variety of bacteria. The compressive strength of the beads was found to be adequate to avoid fragmentation during their clinical use. There was gradual release of tobramycin from the beads over the entire 21 days, but the release was most marked during the first 48 hours. There was antibiotic activity against both gram-negative and gram-positive organisms, except Enterococcus, for the entire 21 day period. The release of tobramycin followed a curvilinear relationship and was directly related to the initial antibiotic concentration of the bead. Tobramycin-impregnated polymethylmethacrylate beads may represent a reliable method of local antibiotic delivery with sustained activity against a broad spectrum of organisms.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3832055     DOI: 10.3928/0147-7447-19850901-09

Source DB:  PubMed          Journal:  Orthopedics        ISSN: 0147-7447            Impact factor:   1.390


  4 in total

1.  Cefoperazone sodium impregnated polycaprolactone composite implant for osteomyelitis.

Authors:  A Anand; R Pundir; C S Pandian; S Saraf; H Gupta
Journal:  Indian J Pharm Sci       Date:  2009-07       Impact factor: 0.975

2.  Treatment of infected hip arthroplasty.

Authors:  Philippe Hernigou; C-H Flouzat-Lachianette; R Jalil; Sobrinho Uirassu Batista; I Guissou; A Poignard
Journal:  Open Orthop J       Date:  2010-03-02

3.  [MRSA-infections-treatment with intraoperatively produced gentamycin-vancomycin PMMA beads].

Authors:  J Kelm; K Anagnostakos; T Regitz; E Schmitt; G Schneider; F Ahlhelm
Journal:  Chirurg       Date:  2004-10       Impact factor: 0.955

Review 4.  Local antibacterial therapy for the management of orthopaedic infections. Pharmacokinetic considerations.

Authors:  S L Henry; K P Galloway
Journal:  Clin Pharmacokinet       Date:  1995-07       Impact factor: 6.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.